Intelligence Feed event · Equity · 2026-10-07

    Neogen Q1 Revenue Rises 6.5% to $222.8M, Beating Consensus Forecasts

    Question

    Neogen Q1 Revenue Rises 6.5% to $222.8M, Beating Consensus Forecasts

    Direct answer

    Food and animal safety testing provider Neogen posted fiscal Q1 2026 results that exceeded Wall Street projections. Revenue climbed 6.5% year-over-year to $222.8 million, delivering a 7.07% positive revenue surprise against consensus estimates. Profitability showed stronger outperformance, with reported EPS of $0.08 beating the $0.05 consensus estimate by 60%, driven by broad operational gains across core testing units.

    Original publisher
    Market Ontology
    Evidence through
    2026-10-07
    Published
    2026-10-20
    Revision
    1 · 2026-10-20

    Cite as: Market Ontology, “Neogen Q1 Revenue Rises 6.5% to $222.8M, Beating Consensus Forecasts”, revision 1, evidence through 2026-10-07. https://marketontology.com/market-events/2026-10-07/neogen-q1-revenue-rises-6-5-to-222-8m-beating-consensus-forecasts-8d1970

    EQUITY
    Neogen Q1 Revenue Rises 6.5% to $222.8M, Beating Consensus Forecasts
    Food and animal safety testing provider Neogen posted fiscal Q1 2026 results that exceeded Wall Street projections. Revenue climbed 6.5% year-over-year to $222.8 million, delivering a 7.07% positive revenue surprise against consensus estimates. Profitability showed stronger outperformance, with reported EPS of $0.08 beating the $0.05 consensus estimate by 60%, driven by broad operational gains across core testing units.
    NEOG
    Impact
    69
    OCT 7
    SIG
    88%
    NEOG
    Neogen Q1 Revenue Rises 6.5% to $222.8M, Beating Consensus Forecasts
    Food and animal safety testing provider Neogen posted fiscal Q1 2026 results that exceeded Wall Street projections. Revenue climbed 6.5% year-over-year to $222.8 million, delivering a 7.07% positive revenue surprise against consensus estimates. Profitability showed stronger outperformance, with reported EPS of $0.08 beating the $0.05 consensus estimate by 60%, driven by broad operational gains across core testing units.
    → A 60% EPS surprise and top-line outperformance trigger upward consensus earnings revisions for NEOG.
    Impact
    Food and animal safety testing provider Neogen posted fiscal Q1 2026 results that exceeded Wall Street projections. Revenue climbed 6.5% year-over-year to $222.8 million, delivering a 7.07% positive revenue surprise against consensus estimates. Profitability showed stronger outperformance, with reported EPS of $0.08 beating the $0.05 consensus estimate by 60%, driven by broad operational gains across core testing units.
    Affected
    NEOG
    Transmission
    A 60% EPS surprise and top-line outperformance trigger upward consensus earnings revisions for NEOG.

    How this development reaches the affected companies

    AssetExposure and channelDirectionEvidence
    NEOGpositive quarterly earnings surprise and margin expansionUp1-5dNeogen reported revenue of $222.8M vs $208.09M est and EPS of $0.08 vs $0.05 est.

    Does this development affect your holdings?

    Enter your holdings to check them against this and other recent developments, review the decision that matters most, then set a monitor.

    Check this development against my holdings

    Review your initial audit before choosing ongoing portfolio scanning at $79/month.

    What happened next

    AssetCallBase close+1 day+5 days+20 days
    NEOGUpagreed11.68 2026-10-07+0.26%PendingPending

    Closing prices from stored daily bars; returns measured from the last close on or before the event date. Not a recommendation.

    No verifiable public source recorded for this card.

    Related

    Check this development against my holdings

    See today's live cards

    Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.

    Open Desk — $399/month